Skip to content
Patch Next
Sign inAdd to your agent

← Actionable
Critical, CVSS 10.0amended

safe-eval vulnerable to Sandbox Bypass due to improper input sanitization

CVE-2023-26122GHSA-79xf-67r4-q2jj

What to do

Vendor response not established. Follow the primary source's mitigation guidance and check back for a fix.

This page has no inventory attached, so it cannot say whether you are affected. A vendor fix is not proof that your deployment is fixed.

Add to your agent

Affected packages

  • npm safe-eval

    Affected
    <= 0.4.2
    Fixed in
    no fixed version recorded

Sources

Severity and exploitation
Exploitation
No confirmed exploitation recorded. Patch Next marks exploitation only from CISA KEV.
CVSS
10.0 · CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
EPSS
  • CVE-2023-26122: 2.10% estimated exploitation activity in the next 30 days; percentile 81.74 (FIRST EPSS, 2026-11-03). This is a model estimate, not proof of exploitation or customer exposure.
Source description

As published by the source; long descriptions are shortened.

All versions of the package safe-eval are vulnerable to Sandbox Bypass due to improper input sanitization. The vulnerability is derived from prototype pollution exploitation. Exploiting this vulnerability might result in remote code execution (RCE). Vulnerable functions: defineGetter, stack(), toLocaleString(), propertyIsEnumerable.call(), valueOf().

Dates and revisions
Published by the source
Last modified by the source
Source last checked
  1. Revision 2 · amended ·

    Amended from ghsa record GHSA-79xf-67r4-q2jj

  2. Revision 1 · created ·

    Published from osv record GHSA-79xf-67r4-q2jj

Agent brief

Preview the exact text before you copy it. Commands are read-only suggestions; review them before running anything.

# Patch Next advisory brief: CVE-2023-26122

Advisory: safe-eval vulnerable to Sandbox Bypass due to improper input sanitization
IDs: CVE-2023-26122, GHSA-79xf-67r4-q2jj
Record: https://patchnext.com/advisories/cve-2023-26122 (revision 2, source checked 26 Oct 2026, 12:22 UTC)
Inventory: none attached. This brief comes from a public page and does not say whether any deployment is affected.
Severity: Critical (CVSS 10.0)
Exploitation: no confirmed exploitation recorded. Patch Next confirms exploitation only from CISA KEV.
Vendor response: Vendor response not established. A vendor fix does not mean a deployment is fixed.

## Affected components
- npm safe-eval: affected <= 0.4.2

## Suggested inspection (read-only)
- `npm ls safe-eval --all`: lists every installed copy and version, including transitive ones. Run in the project root after `npm ci`.

## Supported action
No complete vendor fix is recorded. Follow the primary source's mitigation guidance and check this record again before closing anything.

## Required regression checks
- Run the test suite and a production build.
- Exercise the features that depend on safe-eval.
- Repeat the inspection and confirm that only fixed versions remain installed.

## Rollback considerations
- Keep the previous lockfile and deployment artifact. Rolling back reinstates the vulnerable version, so apply any documented mitigation while you fix forward.

## Unresolved questions
- Which deployments run an affected version?
- Exploitation status can change. Check again before lowering the priority.
- Mark the work resolved only after the fixed version is verified in production.

## Sources
- Verified: https://osv.dev/vulnerability/GHSA-79xf-67r4-q2jj (OSV record GHSA-79xf-67r4-q2jj lists affected ranges: npm safe-eval >=0 <=0.4.2)
- Verified: https://github.com/advisories/GHSA-79xf-67r4-q2jj (GitHub-reviewed advisory GHSA-79xf-67r4-q2jj lists affected ranges: npm safe-eval >=0 <=0.4.2)

Commands are suggestions: review each one before running it.

Loading voting…